Ignite Creation Date:
2025-12-24 @ 11:18 PM
Ignite Modification Date:
2026-01-02 @ 4:13 PM
Study NCT ID:
NCT00084656
Status:
COMPLETED
Last Update Posted:
2022-04-14
First Post:
2004-06-10
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma
Sponsor:
Bristol-Myers Squibb
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-05-31
Start Date Type:
ACTUAL
Primary Completion Date:
2009-10-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-10-31
Completion Date Type:
ACTUAL
First Submit Date:
2004-06-10
First Submit QC Date:
None
Study First Post Date:
2004-06-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2022-03-21
Results First Submit QC Date:
None
Results First Post Date:
2022-04-14
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-04-13
Last Update Post Date:
2022-04-14
Last Update Post Date Type:
ACTUAL